|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 07, 2018 ) The report “Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
https://www.marketsandmarkets.com/Market-Reports/platelet-aggregation-device-market-208068983.html
The Global Platelet Aggregation Devices Market Is Poised to Reach $342.4 Million by 2020, Growing at a CAGR of 21.0% from 2015 to 2020
On the basis of products, the global platelet aggregation devices market is classified into three major segments, namely, systems, reagents, and consumables & accessories. On the basis of applications, the global platelet aggregation devices market is classified into research applications and clinical applications. The clinical applications segment is further classified into three subsegments, namely, cardiovascular, orthopedic, and other clinical applications (includes monitoring of antiplatelet therapy and urology, trauma, and bleeding disorders).
Download PDF Brochure :
https://www.marketsandmarkets.com/pdfdownload.asp?id=208068983
Factors such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies are fuelling the growth of the global platelet aggregation devices market. On the other hand, procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are some of the key factors hampering the growth of this market.
As of 2015, North America is expected to hold the largest share of the platelet aggregation devices market, followed by Europe. Additionally, North America is expected to grow at the highest CAGR during the forecast period (2015 to 2020). Strong market growth witnessed in the North American platelet aggregation devices market can be attributed to factors such as large patient population for target diseases; strong presence of device manufacturers in the region; growing number of surgical procedures; rising awareness among healthcare professionals (regarding the benefits offered by platelet aggregation testing in disease diagnosis); large number of patients undergoing cardiovascular surgeries; and increasing prevalence of orthopedic, urological, and bleeding disorders. F. Hoffmann La-Roche Ltd. (Switzerland), Haemonetics Corporation (U.S.), Sysmex Corporation (Japan), Siemens AG (Germany), Accriva Diagnostics (U.S.), Helena Laboratories Corporation (U.S.), Bio/Data Corporation (U.S.), Tem Group (Switzerland), Sentinel CH. S.p.A. (Italy), and Aggredyne, Inc. (U.S.) are the major players in the global platelet aggregation devices market.
MarketsandMarkets
Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
